NCDR™News
 
Increase Font Size Decrease Font Size Participant Login   
Home
About Us
Program Requirements
Latest News
Research
How to Join
Software Vendors
ACTION Registry® - GWTG™
CARE Registry®
CathPCI Registry®
ICD Registry™
IMPACT Registry™
PINNACLE Registry™
(IC3 Program®)
SPECT-MPI Pilot


News

 
 NCDR’s ACTION Registry-GWTG releases new Limited version (posted: 12/17/09)
The ACTION Registry-GWTG has announced the availability of its new Limited version. This pared down version of the ACTION Registry-GWTG is a 50% reduction in the data collection and was created to allow more hospitals to participate in the registry as well as the AHA's Mission: Lifeline Program. Current registry participants and new participants, who choose the more comprehensive version, will be designated as ACTION Registry-GWTG Premiere participants. ACTION Registry-GWTG Premier, which includes the registry’s most robust set of data elements, will remain the most comprehensive choice for monitoring data in ACS - looking at all the AMI Performance Measures, and all test measures, including dosing errors and lipid metrics.

 D2B Strategies Reduce MI Deaths (posted: 12/04/09)
Seventy five percent of participating hospitals in ACC’s Door-to-Balloon (D2B) Alliance by 2008 were able to treat ST-segment elevation myocardial infarction patients within 90 minutes, the Alliance’s goal, according to a new study from the Journal of the American College of Cardiology (JACC). This data shows that the way care for heart attack patients is delivered can make a life or death difference. “The incredible success of the D2B Alliance represents aspects of the best of health care delivery in the U.S.; the integration of the highest medical science, technology and our medical community through the organization and integration of systems of care leading to seamless translation of evidence based medicine into clinical practice,” says ACC President-Elect Ralph Brindis, M.D., F.A.C.C. For more on the study, view the December 15 – 22 issue of JACC. The study findings were also covered in The Boston Globe (12/2, Kowalczyk), USA Today (12/3, Sternberg) and HealthDay (12/2, Edelson).

 ACCF, AHA Unveil Updated Guidelines for STEMI, PCI  (posted: 11/19/09)
The ACC Foundation, along with the American Heart Association and the Society for Cardiovascular Angiography and Interventions, released a focused update that applies to two sets of Guidelines — the management of patients with ST-elevation myocardial infarction (STEMI) and the management of patients undergoing percutaneous coronary intervention. The update makes new recommendations to ensure patients reach lifesaving therapy for STEMI as quickly as possible.

The update recommends that each community develop a STEMI system for triage and transfer of patients that complies with the standards set forth by Mission Lifeline. The system should include destination protocols to STEMI Receiving Centers and transfer protocols for patients who arrive at STEMI Referral Centers and are primary PCI candidates and/or are fibrinolytic ineligible and/or in cardiogenic shock.

Another significant change recommended in the update is greater acceptance of PCI of the left main coronary artery. The update suggests it may be considered based on favorable anatomic condition and an increased risk of adverse surgical outcomes.

For more recommendations from the focused update, click here.

 Notice for Registry Participants (posted: 11/16/09)
Administrative, technical and training & orientation related news items are no longer posted on the Latest News sections of NCDR.com. All notices of this nature can be viewed under Important Announcements, found on each registry home page within the NCDR password protected Web site. Participants, please log in and visit this section for important registry-related announcements. Thank you.

 Register now for the 11th Annual NCDR Meeting! (posted: 11/03/09)
Registration is now open for the 11th Annual NCDR Meeting taking place on March 11 and 12, 2010, with preconferences on March 10. Building on previous years, the 2010 meeting promises to provide even more hands-on case studies, story boards, informative speakers, workshops and networking. As part of the 2010 renewal process, each NCDR participating facility is entitled one free registration per NCDR registry for which they are contracted, compliments of the NCDR. The promo code required to take advantage of this free registration has been sent by email to each participating facility’s registry site manager. Please follow these links to view the Meeting Agenda and to Register.

 The IC3 Program® officially becomes the PINNACLE RegistryTM (posted: 11/02/09)
After two years of mounting success with the IC3 Program pilot, the ACC’s NCDR® is pleased to announce that the IC3 Program is now the PINNACLE Registry. The PINNACLE Registry will continue to build on the success of the IC3 Program while serving as the foundation for the much larger PINNACLE NetworkTM, a suite of clinical and financial solutions designed to provide practices with the tools they need to promote practice innovations and achieve clinical excellence in this rapidly shifting business environment. Visit PINNACLEnetwork.org for more information.

 Breaking News (posted: 10/08/09)
The ACTION Registry-GWTG methodology paper; A Call to ACTION (Acute Coronary Treatment and Intervention Outcomes Network) A National Effort to Promote Timely Clinical Feedback and Support Continuous Quality Improvement for Acute Myocardial Infarction, has been published in the October, 2009 issue of Circulation: Cardiovascular and Quality Outcomes. The paper is available for review at this link. Contact the NCDR service center at 800-257-4737 with any questions.

 ACC and STS receive grant to study comparative effectiveness of PCI and CABG (posted: 10/07/09)
The American College of Cardiology (ACC) in partnership with The Society of Thoracic Surgeons (STS) has been awarded a grant by the National Heart, Lung, and Blood Institute of the National Institutes of Health (NIH) to study the comparative effectiveness of the two forms of coronary revascularization; percutaneous coronary intervention (PCI) and coronary artery bypass graft (CABG) surgery.

This study, led by our own Drs. Bill Weintraub (CathPCI Registry Chair) and Fred Edwards (STS PI), will compare catheter-based and surgery-based procedures using the NCDR®’s CathPCI Registry® and STS’s Adult Cardiac Surgery Database, as well as the Centers for Medicare and Medicaid Services’ MEDPAR data. By linking these three databases, the study will help physicians make better decisions and improve healthcare for patients with coronary artery disease.

Click here for the full press release.

 Share the CardioSmart eNewsletter with your Patients  (posted: 10/03/09)
Share the latest news on cardiovascular disease with your patients with CardioSmart’s" new biweekly eNewsletter.

 FDA Awards Contract to ACCF for CHD Registry (posted: 10/02/09)
The FDA recently awarded a contract to the American College of Cardiology Foundation for the development of a congenital heart disease registry. The contract, intended to increase the scientific knowledge base for congenital heart disease, will further assist in the development of NCDR's IMPACT Registry. The IMPACT Registry, which is currently piloting 15 sites, tracks the prevalence, demographics, management and outcomes of pediatric and adult patients with congenital heart disease who are undergoing diagnostic catheterizations and catheter-based interventions. For more information on the IMPACT Registry, click here.

 Cardiovascular Business: Expanded ICD registry corrects previous limitations, offers data on leads (posted: 09/17/09)
In a recent article published online, Cardiovascular Business highlighted key findings from the Annual Report and discussed the registry's planned Version 2.0 expansion. To read the full article, titled "Expanded ICD registry corrects previous limitations, offers data on leads," click here.

 The EASIEST Test You'll Ever Take (posted: 09/01/09)
Are you at risk of developing diabetes? Nearly 24 million people in the United States have it, but a surprising 5 million (or more) don't even know it. To assess your risk - and learn more about the disease and its effects - visit diabetes.org. The site's simple 8-question test can even suggest your level of risk: pre-diabetes, at risk, or Type 2 level. Click on the Nutrition tab and go to Lifestyle & Prevention to access the test.
 Class I Recall of Abbott Catheter (posted: 08/25/09)
Abbott and the Food and Drug Administration have issued a national Class1 recall of four lots of POWERSAIL Coronary Dilatation Catheters after complaints that the distal shaft of the catheter exhibited damage. This damage could lead to catheter functional failures and air embolism and myocardial infarction. Customers with questions should call the company at 1-800-227-9902. Any adverse reactions experienced with this product, and/or quality problems should be reported to the FDA's MedWatch Adverse Event Reporting program online or by phone at 1-800-332-1088.
 Annual Meeting Questions Answered (posted: 08/21/09)
All the questions that were submitted during the 10th NCDR Annual Meeting that was held in Orlando this year and their answers have been posted. (link) They have been placed in an Excel format and sorted by topic (note the tabs on the bottom of the Excel page). Please feel free to peruse them even if you did not attend the Annual Meeting. We hope that you find them helpful.

 NCDR IMPACT Registry™ featured in Wall Street Journal article (posted: 08/18/09)
The NCDR's IMPACT Registry™ recently gained some important national recognition in an article published in The Wall Street Journal on Wednesday, August 12. The article, titled “Little Hearts, Big Problems,” highlighted the plight of congenital heart disease (CHD) physicians and patients who struggle with a lack of both evidence and technology. Acknowledging that “hardly any of the myriad drugs and devices developed for the multibillion-dollar market for cardiovascular disease are designed with kids in mind,” the article goes on to discuss the role the Registry will play in addressing this issue. Gerard Martin, M.D., F.A.C.C., was quoted in the article discussing the soon-to-launch IMPACT Registry: “‘We hope IMPACT will become the standard by which safety and quality are judged for hospitals’ that treat congenital defects, says Gerard R. Martin, co-director of the Children’s National Heart Institute in Washington, who heads the registry effort. Dr. Martin expects the registry will eventually enable doctors to see whether surgery or less-invasive catheter-based procedures achieve better results for a variety of heart defects,” the article says.

Filling in some of the gaps in research will be NCDR’s IMPACT Registry™ (For Improving Pediatric and Adult Congenital Treatment). The IMPACT Registry will assess the prevalence, demographics, management and outcomes of pediatric and adult patients with congenital heart disease who are undergoing diagnostic catheterizations and catheter-based interventions. The IMPACT Registry will provide significant contributions to the knowledge base and outcomes associated with congenital heart disease. For more information, visit: http://www.impact.ncdr.com.

 National Comparative Effectiveness Summit, Washington, DC (posted: 08/17/09)
This conference, which was held on September 16 and 17, 2009 will be archived online for six months. Please follow this link to learn more: A Hybrid Conference and Internet Event

 Stroke Statistics Available (posted: 08/17/09)
Do you ever need a statistic on the number of African-Americans who may have a stroke this year? The American Heart Association provides an updated comprehensive compilation of national statistics on heart disease, stroke and risk factors in the Heart Disease and Stroke Statistics 2009 Update. It's free online at americanheart.org. In addition to statistics, the Update includes charts and graphs and is revised every year in January with the most up-to-date statistics. An At-A-Glance version is available also.
 Pfizer Announces Patient Assistance Program  (posted: 06/18/09)

Pfizer recently announced a new patient assistance program for people who lost their jobs in 2009. The program, called MAINTAIN (Medicines Assistance for those In Need) is designed to help recently unemployed Americans and their families who have lost their insurance and who are taking Pfizer medicines to continue treatment at no cost for up to one year. The program will be open for enrollment through December 31, 2009 and applies to eligible Americans who have become unemployed since January 1, 2009.

*Download the Fact Sheet

*Download a printable Patient Flyer


Home | Contact Us
© 2010 American College of Cardiology Foundation. All rights reserved.
Terms and Conditions | Privacy Policy